PharmaSynth

PharmaSynth AS is a specialized contract manufacturing organization (CMO) based in Estonia that focuses on the custom synthesis of complex organic molecules and active pharmaceutical ingredients (APIs). Established in 2004 and headquartered in the Tartu Science Park, the company provides essential services to the global pharmaceutical and biotechnology sectors, ranging from laboratory-scale process development to pilot-plant production. Their core expertise lies in multi-step organic synthesis and the production of novel drug candidates and chemical intermediates under Good Manufacturing Practice (GMP) standards. PharmaSynth serves as a strategic partner for R&D-stage firms, facilitating the transition of therapeutic candidates from initial discovery through to clinical trial supply. By leveraging a team of experienced synthetic chemists, the company ensures high-purity materials and rigorous quality control for its international client base. PharmaSynth remains a key player in the Northern European life sciences ecosystem, supporting small molecule innovation across various therapeutic categories.